Drugs / key limpet hemocyanin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00275262 Background | Feb 2006 → Feb 2009 | Hodgkins lymphoma, mantle cell lymphoma, plasma cell myeloma | Abbott | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | key limpet hemocyanin | “a subcutaneous key limpet hemocyanin (KLH) vaccination injection (1 mg)” NCT00275262 ↗ |
| Known as | KLH | “a subcutaneous key limpet hemocyanin (KLH) vaccination injection (1 mg)” NCT00275262 ↗ |
| Modality | Vaccine | “KLH vaccination injection (1 mg)” NCT00275262 ↗ |
| Route | Subcutaneous | “a subcutaneous key limpet hemocyanin (KLH) vaccination injection (1 mg)” NCT00275262 ↗ |